Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Functionality Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Patient Engagement Solutions Market 

5.1. COVID-19 Landscape: Patient Engagement Solutions Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Patient Engagement Solutions Market, By Delivery Type

8.1. Patient Engagement Solutions Market, by Delivery Type, 2023-2032

8.1.1. Web-based/Cloud-based

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. On-premise

8.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Patient Engagement Solutions Market, By Component

9.1. Patient Engagement Solutions Market, by Component Type, 2023-2032

9.1.1. Software

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Services

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Hardware

9.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Patient Engagement Solutions Market, By End Use

10.1. Patient Engagement Solutions Market, by End Use Type, 2023-2032

10.1.1. Payers

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Providers

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Individual Users

10.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Patient Engagement Solutions Market, By Application

11.1. Patient Engagement Solutions Market, by Application Type, 2023-2032

11.1.1. Social Management

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Health Management

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Home Healthcare Management

11.1.3.1. Market Revenue and Forecast (2021-2032)

11.1.4. Financial Health Management

11.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Patient Engagement Solutions Market, By Therapeutic Area

12.1. Patient Engagement Solutions Market, by Therapeutic Area, 2023-2032

12.1.1. Chronic Diseases

12.1.1.1. Market Revenue and Forecast (2021-2032)

12.1.2. Fitness

12.1.2.1. Market Revenue and Forecast (2021-2032)

12.1.3. Women’s Health

12.1.3.1. Market Revenue and Forecast (2021-2032)

12.1.4. Mental Health

12.1.4.1. Market Revenue and Forecast (2021-2032)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 13. Global Patient Engagement Solutions Market, By Functionality

13.1. Patient Engagement Solutions Market, by Component Type, 2023-2032

13.1.1. Communication

13.1.1.1. Market Revenue and Forecast (2021-2032)

13.1.2. Health Tracking & Insights

13.1.2.1. Market Revenue and Forecast (2021-2032)

13.1.3. Billing & Payments

13.1.3.1. Market Revenue and Forecast (2021-2032)

13.1.4. Administrative

13.1.4.1. Market Revenue and Forecast (2021-2032)

13.1.5. Patient Education

13.1.5.1. Market Revenue and Forecast (2021-2032)

13.1.6. Others

13.1.6.1. Market Revenue and Forecast (2021-2032)

Chapter 14. Global Patient Engagement Solutions  Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.1.2. Market Revenue and Forecast, by Component (2021-2032)

14.1.3. Market Revenue and Forecast, by End Use (2021-2032)

14.1.4. Market Revenue and Forecast, by Application (2021-2032)

14.1.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.1.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.1.7.2. Market Revenue and Forecast, by Component (2021-2032)

14.1.7.3. Market Revenue and Forecast, by End Use (2021-2032)

14.1.7.4. Market Revenue and Forecast, by Application (2021-2032)

14.1.8. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.1.8.1. Market Revenue and Forecast, by Functionality (2021-2032) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.1.9.2. Market Revenue and Forecast, by Component (2021-2032)

14.1.9.3. Market Revenue and Forecast, by End Use (2021-2032)

14.1.9.4. Market Revenue and Forecast, by Application (2021-2032)

14.1.10. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.1.11. Market Revenue and Forecast, by Functionality (2021-2032)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.2.2. Market Revenue and Forecast, by Component (2021-2032)

14.2.3. Market Revenue and Forecast, by End Use (2021-2032)

14.2.4. Market Revenue and Forecast, by Application (2021-2032) 

14.2.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.2.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.2.8.2. Market Revenue and Forecast, by Component (2021-2032)

14.2.8.3. Market Revenue and Forecast, by End Use (2021-2032)

14.2.9. Market Revenue and Forecast, by Application (2021-2032) 

14.2.10. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.2.10.1. Market Revenue and Forecast, by Functionality (2021-2032) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.2.11.2. Market Revenue and Forecast, by Component (2021-2032)

14.2.11.3. Market Revenue and Forecast, by End Use (2021-2032)

14.2.12. Market Revenue and Forecast, by Application (2021-2032)

14.2.13. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.2.14. Market Revenue and Forecast, by Functionality (2021-2032)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.2.15.2. Market Revenue and Forecast, by Component (2021-2032)

14.2.15.3. Market Revenue and Forecast, by End Use (2021-2032)

14.2.15.4. Market Revenue and Forecast, by Application (2021-2032)

14.2.16. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.2.16.1. Market Revenue and Forecast, by Functionality (2021-2032)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.2.17.2. Market Revenue and Forecast, by Component (2021-2032)

14.2.17.3. Market Revenue and Forecast, by End Use (2021-2032)

14.2.17.4. Market Revenue and Forecast, by Application (2021-2032)

14.2.18. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.2.18.1. Market Revenue and Forecast, by Functionality (2021-2032)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.3.2. Market Revenue and Forecast, by Component (2021-2032)

14.3.3. Market Revenue and Forecast, by End Use (2021-2032)

14.3.4. Market Revenue and Forecast, by Application (2021-2032)

14.3.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.3.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.3.7.2. Market Revenue and Forecast, by Component (2021-2032)

14.3.7.3. Market Revenue and Forecast, by End Use (2021-2032)

14.3.7.4. Market Revenue and Forecast, by Application (2021-2032)

14.3.8. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.3.9. Market Revenue and Forecast, by Functionality (2021-2032)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.3.10.2. Market Revenue and Forecast, by Component (2021-2032)

14.3.10.3. Market Revenue and Forecast, by End Use (2021-2032)

14.3.10.4. Market Revenue and Forecast, by Application (2021-2032)

14.3.11. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.3.11.1. Market Revenue and Forecast, by Functionality (2021-2032)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.3.12.2. Market Revenue and Forecast, by Component (2021-2032)

14.3.12.3. Market Revenue and Forecast, by End Use (2021-2032)

14.3.12.4. Market Revenue and Forecast, by Application (2021-2032)

14.3.12.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.3.12.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.3.13.2. Market Revenue and Forecast, by Component (2021-2032)

14.3.13.3. Market Revenue and Forecast, by End Use (2021-2032)

14.3.13.4. Market Revenue and Forecast, by Application (2021-2032)

14.3.13.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.3.13.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.4.2. Market Revenue and Forecast, by Component (2021-2032)

14.4.3. Market Revenue and Forecast, by End Use (2021-2032)

14.4.4. Market Revenue and Forecast, by Application (2021-2032)

14.4.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.4.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.4.7.2. Market Revenue and Forecast, by Component (2021-2032)

14.4.7.3. Market Revenue and Forecast, by End Use (2021-2032)

14.4.7.4. Market Revenue and Forecast, by Application (2021-2032)

14.4.8. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.4.9. Market Revenue and Forecast, by Functionality (2021-2032)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.4.10.2. Market Revenue and Forecast, by Component (2021-2032)

14.4.10.3. Market Revenue and Forecast, by End Use (2021-2032)

14.4.10.4. Market Revenue and Forecast, by Application (2021-2032)

14.4.11. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.4.12. Market Revenue and Forecast, by Functionality (2021-2032)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.4.13.2. Market Revenue and Forecast, by Component (2021-2032)

14.4.13.3. Market Revenue and Forecast, by End Use (2021-2032)

14.4.13.4. Market Revenue and Forecast, by Application (2021-2032)

14.4.13.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.4.13.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.4.14.2. Market Revenue and Forecast, by Component (2021-2032)

14.4.14.3. Market Revenue and Forecast, by End Use (2021-2032)

14.4.14.4. Market Revenue and Forecast, by Application (2021-2032)

14.4.14.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.4.14.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.5.2. Market Revenue and Forecast, by Component (2021-2032)

14.5.3. Market Revenue and Forecast, by End Use (2021-2032)

14.5.4. Market Revenue and Forecast, by Application (2021-2032)

14.5.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.5.6. Market Revenue and Forecast, by Functionality (2021-2032)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.5.7.2. Market Revenue and Forecast, by Component (2021-2032)

14.5.7.3. Market Revenue and Forecast, by End Use (2021-2032)

14.5.7.4. Market Revenue and Forecast, by Application (2021-2032)

14.5.8. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.5.8.1. Market Revenue and Forecast, by Functionality (2021-2032)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Delivery (2021-2032)

14.5.9.2. Market Revenue and Forecast, by Component (2021-2032)

14.5.9.3. Market Revenue and Forecast, by End Use (2021-2032)

14.5.9.4. Market Revenue and Forecast, by Application (2021-2032)

14.5.9.5. Market Revenue and Forecast, by Therapeutic Area (2021-2032)

14.5.9.6. Market Revenue and Forecast, by Functionality (2021-2032)

Chapter 15. Company Profiles

15.1. McKesson Corporation

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Allscripts Healthcare Solutions

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Orion Health Ltd.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. GetWellNetwork Inc.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Cerner Corporation

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Medecision Inc.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Phytel Inc.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Athenahealth Inc.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. YourCareUniverse Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Lincor Solutions Ltd.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms